{
  "pdfPath": "/home/arkantu/Documentos/Zotero Biblioteca/Neurología/Clinical practice/Clinical Reasoning/Wong et al. - 2015 - Clinical Reasoning A 27-year-old man with rapidly.pdf",
  "fileName": "Wong et al. - 2015 - Clinical Reasoning A 27-year-old man with rapidly.pdf",
  "relativePath": "Neurología/Clinical practice/Clinical Reasoning/Wong et al. - 2015 - Clinical Reasoning A 27-year-old man with rapidly.pdf",
  "text": "RESIDENT\n               & FELLOW\n               SECTION\n                          Clinical Reasoning:\nSection Editor            A 27-year-old man with rapidly progressive\nJohn J. Millichap, MD\n                          coma\n\nJonathan M. Wong, MD      SECTION 1                                                                              Two weeks prior to this admission, he had presented\nMekhala Chandra, MD       A 27-year-old man was brought to the emergency                                     to an emergency department for an upper respiratory\nRachael VanDeBogart,      department by paramedics after being found wander-                                 illness with signs of mild confusion that spontaneously\n  MD                      ing the street not communicative and with unsteady                                 and completely resolved shortly thereafter.\nBrandon Lu, MD            gait. At the scene, he was noted to have full body                                     His only prescription medication was bupropion\nAlan H. Yee, DO           tremulousness, which improved after receiving mida-                                for depression. His medical history included tetral-\n                          zolam. He was urgently transported to an emergency                                 ogy of Fallot with an associated ventricular septal\n                          department and subsequently developed nausea, vom-                                 defect that was surgically corrected in youth, as well\nCorrespondence to         iting, and progressive deterioration of his mental status.                         as pulmonic valve repair 4 years prior. He was em-\nDr. Yee:\nyeeah@sutterhealth.org\n                          On physical examination, he had tachycardia without                                ployed as the CEO of a start-up Internet company\n                          fever, and was hemodynamically stable with normal                                  and consumed occasional alcohol and marijuana\n                          oxygen saturation. He was stuporous; however, all                                  socially. He had no familial history of neurologic\n                          brainstem reflexes were preserved with symmetrically                               disease.\n                          reactive pupils of normal shape and size. He demon-\n                                                                                                             Questions for consideration:\n                          strated spontaneous symmetrical limb movement as\n                          well as purposeful withdrawal. He had anicteric sclera,                            1. What are your differential diagnoses at this point?\n                          and his dermatologic evaluation showed no rash, nee-                               2. What other investigations would help narrow the\n                          dle track marks, or focal signs of external trauma.                                   differential?\n\n\n\n\n                                                                                                                                                             GO TO SECTION 2\n\n\n\n\n                          From the California Pacific Medical Center, San Francisco.\n                          Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.\n\ne74                       © 2015 American Academy of Neurology\n\n   ª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.\n\f                                SECTION 2                                                        free T4 levels. Urinalysis and toxicology screening iden-\n                                The differential diagnosis for rapidly progressive stu-          tified sterile ketonuria, the presence of benzodiazepines\n                                por and coma in young adults is broad (table 1).1                and tetrahydrocannabinol, and a normal salicylate level.\n                                Meningoencephalitis, toxic ingestion or substance                Shortly after presentation, he developed airway com-\n                                abuse, or a severe systemic metabolic process were               promise due to progressive obtundation requiring\n                                the leading diagnostic considerations. Initial evalua-           endotracheal intubation and was admitted to the inten-\n                                tion with basic laboratory studies, urine toxicology,            sive care unit for suspected meningoencephalitis. CSF\n                                and brain imaging are helpful in narrowing the                   analysis immediately following empiric initiation of\n                                diagnosis.                                                       broad-spectrum antimicrobial therapy yielded largely\n                                    Our patient’s initial complete blood count, meta-            noninflammatory findings (3 leukocytes, 0 erythro-\n                                bolic panel with liver enzymes and coagulation studies,          cytes, 72 mg/dL glucose, 54 mg/dL protein). Serologic\n                                cardiac biomarkers, and chest X-ray were normal. An              and PCR studies for herpes simplex virus, varicella-\n                                ECG revealed sinus tachycardia with a right bundle-              zoster virus, West Nile virus, and syphilis were negative,\n                                branch block and precordial T-wave inversions. The               as well as the presence of HIV antibodies.\n                                initial cranial CT was unremarkable. He was found to                  Although viral meningoencephalitides can present\n                                have lactic acidosis of 5.5 mmol/L (ref: 0.5–2.2 mmol/           in an indolent manner, a fulminate bacterial process\n                                L) and low thyroid-stimulating hormone but normal                was unlikely given the diagnostic results thus far.\n\n\nTable 1        Causes of stupor and coma in adults1\n\nPrimary brain disorders   Metabolic derangements        Drugs and toxins   Organ failure    Injury           Endocrinopathies              Infection\n\nPostictal state           Hyperglycemia/hypoglycemia    Alcohol            Cardiac arrest   Asphyxiation     Myxedema coma                 Bacterial\n                                                                                                                                           meningitis\n\nStatus epilepticus        Hypernatremia/hyponatremia    Carbon monoxide    Heart failure    Head trauma      Thyroid storm                 Viral meningitis\n\nIschemic stroke           Hypercalcemia/hypocalcemia    Ethylene glycol    Lung disease     Hyperthermia     Acute adrenal insufficiency   Sepsis\n\nIntracranial hemorrhage   Hypoxia/hypercarbia           Opioids            Kidney failure   Hypothermia      Diabetic ketoacidosis and     Waterhouse-\n                                                                                                             hyperosmolar hyperglycemic    Friderichsen\n                                                                                                             nonketotic coma               syndrome\n\nSubarachnoid              Acidosis/alkalosis            Sedatives          Liver failure                                                   Typhoid fever\nhemorrhage\n\nTumor                     Hypophosphatemia              Tranquilizers                                                                      Rabies\n\nAbscess                   Reye encephalopathy           Anticholinergics\n\nVasculitis                Porphyria                     Psychotropics\n\nHydrocephalus             Lactic acidosis\n\n                          Hyperammonemia\n\n\n\n\n                                   Figure       MRI of the brain\n\n\n\n\n                                (A) Diffusion-weighted and (B) apparent diffusion coefficient MRI of the brain show extensive cytotoxic injury within the cor-\n                                tex of the bilateral frontal, temporal, and occipital lobes and insular cortex.\n\n\n\n                                                                                                 Neurology 85   September 1, 2015                          e75\n\nª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.\n\f                    Antimicrobial therapy was further tapered to only          pupils and pathologic extensor posturing. Repeat cra-\n                    acyclovir as all bacterial cultures remained negative.     nial imaging confirmed the presence of new extensive\n                    Moreover, a focal intracranial process was not seen        cerebral edema and severe bilateral uncal herniation.\n                    on initial cranial imaging, making intracranial hemor-     Given the unusual pattern of diffuse cortical injury\n                    rhage, tumor, and trauma unlikely.                         noted on MRI, an ammonia level was obtained and\n                        The patient developed frequent nonstereotypic          found to be markedly abnormal at 569 mmol/L, greater\n                    multifocal myoclonus of the face, trunk, and limbs.        than 15 times that of normal levels (ref: 11–32\n                    His eyes had persistent downward deviation through-        mmol/L). He subsequently developed electrographic\n                    out the adventitial body movements but were without        status epilepticus refractory to 3 anticonvulsants.\n                    accompanying nystagmus. Continuous EEG moni-\n                                                                               Questions for consideration:\n                    toring did not demonstrate an ictal correlate initially.\n                    A brain MRI obtained 12 hours after admission              1. What is the differential diagnosis for hyperammo-\n                    showed diffuse bihemispheric abnormalities (figure).          nemic crisis?\n                    He rapidly deteriorated nearly 48 hours following          2. What additional testing would you pursue to nar-\n                    symptom onset and developed progressive signs of              row your differential diagnosis?\n                    brainstem dysfunction with bilateral fixed and dilated     3. What therapy would you initiate?\n\n\n\n\n                                                                                                               GO TO SECTION 3\n\n\n\n\ne76                 Neurology 85   September 1, 2015\n\n  ª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.\n\f                  SECTION 3                                                 error of metabolism was now a much greater diagnos-\n                  There are numerous causes of hyperammonemia in            tic possibility.\n                  adults (table 2).2 An ammonia level should be con-            The patient received hyperosmolar therapy with\n                  sidered in the initial evaluation of young adults who     mannitol and hypertonic saline along with other\n                  develop rapid decline in mental status without an         aggressive medical treatment for pathologic elevation\n                  obvious etiology, even in the absence of liver disease.   in intracranial pressure (ICP) including chemical\n                  Medications such as valproic acid can reduce the          sedation, paralysis, and mild hypothermia (33°C).\n                  elimination of ammonia; however, the patient’s his-       Despite this, he continued to demonstrate persistent\n                  tory and toxicology profile did not suggest inadver-      signs of pathologic ICP elevation. Given the probable\n                  tent medication ingestion, toxin exposure, or drug        poor neurologic prognosis and family’s wishes, fur-\n                  overdose. Herpetic infections and seizures may lead       ther surgical intervention, such as ICP monitor place-\n                  to secondary elevation of ammonia concentrations          ment, was not pursued. Ammonia levels continued to\n                  but not typically to such striking levels. An inborn      rise and peaked at 2,191 mmol/L despite initiation of\n                                                                            continuous renal replacement therapy 72 hours after\n                                                                            symptom onset. Additional metabolic investigation\n                    Table 2           Causes of hyperammonemia in adults2   revealed marked elevation of urinary orotic acid, con-\n                                                                            sistent with the diagnosis of ornithine transcarbamy-\n                    Increased ammonia production\n                                                                            lase (OTC) deficiency. He died 5 days after admission\n                      Infection\n                                                                            due to cardiovascular compromise from progressive\n                        Urease-producing bacteria\n                                                                            cerebral herniation and likely brain death. An autopsy\n                          Proteus                                           confirmed the presence of diffuse cerebral edema with\n                          Klebsiella                                        patchy cortical ganglionecrosis and uncal herniation.\n                        Herpes infection                                    The liver was of average size and shape, and histologic\n                      Protein load\n                                                                            examination demonstrated sinusoidal congestion but\n                                                                            no cirrhosis.\n                        Extreme exercise\n\n                        Seizure\n                                                                            DISCUSSION OTC deficiency is caused by mutations\n                        Trauma and burns                                    of the OTC gene, located on the X chromosome, which\n                        Steroids                                            is expressed in the liver and gut. The disease tends to\n                        Chemotherapy                                        affect neonatal boys severely; however, adult-onset\n                        Starvation\n                                                                            disease has been described.3 In hyperammonemic\n                                                                            crisis, rapidly progressive encephalopathy with signs of\n                        Gastrointestinal hemorrhage\n                                                                            raised intracranial pressure is its most severe phenotype.\n                        Total parenteral nutrition\n                                                                            Neurologic manifestations are common and include\n                      Other\n                                                                            myoclonus,4 seizure, and status epilepticus, among\n                        Multiple myeloma                                    other signs of cortical dysfunction. Prior case series\n                        Renal failure                                       suggest that OTC deficiency can be characterized on\n                    Decreased ammonia elimination                           MRI by extensive cortical involvement that includes\n                                                                            the insular and cingulate cortices, as these areas may\n                      Liver failure\n                                                                            be particularly vulnerable to hyperammonemic-\n                        Fulminant hepatic failure\n                                                                            hyperglutaminergic states.5 Refractory elevation of\n                        Transhepatic intrajugular portosystemic shunt\n                                                                            ICP and status epilepticus are challenging to manage\n                      Drugs                                                 and may lead to death. Although the precise\n                        Valproate                                           mechanisms of ammonia-associated cerebral toxicity\n                        Carbamazepine                                       are not fully understood, it is believed to cause\n                        Sulfadiazine\n                                                                            cerebral edema through glutamine accumulation\n                                                                            within astrocytes and metabolic disturbances through\n                        Salicylates\n                                                                            a variety of mechanisms.4\n                        Glycine\n                                                                                Carriers of the genetic defect may develop mild,\n                      Inborn errors of metabolism                           nonspecific symptoms that include confusion, nau-\n                        Ornithine transcarbamylase deficiency               sea, irritability, cognitive deficits, bizarre behavior,\n                        Carbamyl synthetase deficiency                      and protein aversion. The more severe clinical mani-\n                        Hypermethioninemia\n                                                                            festation is hyperammonemic crisis.4 The phenotypic\n                                                                            variation seen in OTC deficiency, even among family\n                        Organic acidurias\n                                                                            members who share the same mutation, may result\n                        Fatty acid oxidation defects\n                                                                            from the OTC genotypic heterogeneity as well as\n\n                                                                            Neurology 85   September 1, 2015                     e77\n\nª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.\n\f                    variability in environmental and developmental fac-                         REFERENCES\n                    tors.6 Stressors include the postoperative period,7 use                      1. Bradley WG. Neurology in Clinical Practice, 4th ed.\n                                                                                                    Philadelphia: Butterworth-Heinemann; 2004.\n                    of high-dose corticosteroids,8 and high protein con-\n                                                                                                 2. Clay AS, Hainline BE. Hyperammonemia in the ICU.\n                    sumption (e.g., Atkins diet).9 Plasma amino and urine\n                                                                                                    Chest 2007;132:1368–1378.\n                    organic acid levels are typically abnormal in OTC                            3. Lien J, Nyhan WL, Barshop BA. Fatal initial adult-onset\n                    deficiency—elevated concentrations of plasma gluta-                             presentation of urea cycle defect. Arch Neurol 2007;64:\n                    mine or alanine as well as urinary orotic acid and                              1777–1779.\n                    uracil are frequently seen. DNA sequence analysis often                      4. Walker V. Ammonia toxicity and its prevention in inher-\n                    identifies an associated mutation. Treatment strategies                         ited defects of the urea cycle. Diabetes Obes Metab 2009;\n                                                                                                    11:823–835.\n                    involve reducing serum ammonia levels quickly with\n                                                                                                 5. Takanashi J, Barkovich AJ, Cheng SF, Kostiner D,\n                    combination therapy including hemodialysis, dietary                             Baker JC, Packman S. Brain MR imaging in acute hyper-\n                    protein restriction, and sodium scavengers such as                              ammonemic encephalopathy arising from late-onset orni-\n                    sodium phenyl acetate and sodium benzoate.10                                    thine transcarbamylase deficiency. Am J Neuroradiol\n                       Adult-onset OTC deficiency is rare but may have                              2003;24:390–393.\n                    catastrophic neurologic consequences if not detected                         6. Finkelstein JE, Hauser ER, Leonard CO, Brusilow SW.\n                                                                                                    Late-onset ornithine transcarbamylase deficiency in male\n                    early. Early identification and aggressive treatment\n                                                                                                    patients. J Pediatr 1990;117:897–902.\n                    of hyperammonemia may potentiate its effects with                            7. Hu WT, Kantarci OH, Merritt JL II et al. Ornithine\n                    reasonable neurologic outcome.                                                  transcarbamylase deficiency presenting as encephalopathy\n                                                                                                    during adulthood following bariatric surgery. Arch Neurol\n                    AUTHOR CONTRIBUTIONS\n                                                                                                    2007;64:126–128.\n                    Dr. Jonathan M. Wong: drafting the manuscript, manuscript concept/\n                                                                                                 8. Lipskind S, Loanzon S, Simi E, Ouyang DW. Hyperam-\n                    design. Dr. Mekhala Chandra: critical revision of the manuscript. Dr.\n                                                                                                    monemic coma in an ornithine transcarbamylase mutation\n                    Rachael VanDeBogart: critical revision of the manuscript. Dr. Brandon Lu:\n                    critical revision of the manuscript. Dr. Alan H. Yee: manuscript concept/\n                                                                                                    carrier following antepartum corticosteroids. J Perinatol\n                    design, critical revision of the manuscript, manuscript supervision.            2011;31:682–684.\n                                                                                                 9. Ben-Ari Z, Dalal A, Morry A, et al. Adult-onset ornithine\n                    STUDY FUNDING                                                                   transcarbamylase (OTC) deficiency unmasked by the At-\n                    No targeted funding reported.                                                   kins’ diet. J Hepatol 2010;52:292–295.\n                                                                                                10. Enns GM, Berry SA, Berry GT, Rhead WJ, Brusilow SW,\n                    DISCLOSURE                                                                      Hamosh A. Survival after treatment with phenyl acetate\n                    The authors report no disclosures relevant to the manuscript. Go to             and benzoate for urea-cycle disorders. N Engl J Med 2007;\n                    Neurology.org for full disclosures.                                             356:2282–2292.\n\n\n\n\ne78                 Neurology 85       September 1, 2015\n\n  ª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.\n\f         Clinical Reasoning: A 27-year-old man with rapidly progressive coma\n            Jonathan M. Wong, Mekhala Chandra, Rachael VanDeBogart, et al.\n                              Neurology 2015;85;e74-e78\n                         DOI 10.1212/WNL.0000000000001887\n\n                      This information is current as of August 31, 2015\n\n Updated Information &              including high resolution figures, can be found at:\n Services                           http://www.neurology.org/content/85/9/e74.full.html\n\n References                         This article cites 9 articles, 1 of which you can access for free at:\n                                    http://www.neurology.org/content/85/9/e74.full.html##ref-list-1\n Subspecialty Collections           This article, along with others on similar topics, appears in the\n                                    following collection(s):\n                                    Coma\n                                    http://www.neurology.org//cgi/collection/coma\n                                    Metabolic disease (inherited)\n                                    http://www.neurology.org//cgi/collection/metabolic_disease_inherited\n                                    MRI\n                                    http://www.neurology.org//cgi/collection/mri\n Permissions & Licensing            Information about reproducing this article in parts (figures,tables) or in\n                                    its entirety can be found online at:\n                                    http://www.neurology.org/misc/about.xhtml#permissions\n Reprints                           Information about ordering reprints can be found online:\n                                    http://www.neurology.org/misc/addir.xhtml#reprintsus\n\n\n\n\nNeurology ® is the official journal of the American Academy of Neurology. Published continuously since\n1951, it is now a weekly with 48 issues per year. Copyright © 2015 American Academy of Neurology. All\nrights reserved. Print ISSN: 0028-3878. Online ISSN: 1526-632X.",
  "wordCount": 2119,
  "indexed": "2025-09-25T22:55:14.801Z",
  "method": "direct"
}
